Osteoporosis: Estrogen

There is growing interest in extending the use of adjuvant endocrine therapy in breast cancer, but the benefit vs risk for toxicity is not yet defined.

Rheumatoid arthritis (RA) is characterized, among other factors, by systemic bone loss, reaching ~50% prevalence of osteoporosis in postmenopausal women. This…

The USPSTF has issued a recommendation against using estrogen or estrogen plus progestin to prevent chronic conditions in postmenopausal women.